Vital epidemiologic clues in heart failure.

[1]  J. Cleland,et al.  Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. , 1998, European heart journal.

[2]  P. Heidenreich,et al.  Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. , 1997, Journal of the American College of Cardiology.

[3]  D E Grobbee,et al.  The epidemiology of heart failure. , 1997, European heart journal.

[4]  Gandhi Mm.  Clinical epidemiology of coronary heart disease in the UK. , 1997 .

[5]  Kannel Wb,et al.  Comparison of risk profiles for cardiovascular events: implications for prevention. , 1997 .

[6]  G. Sinagra,et al.  Epidemiology of dilated cardiomyopathy , 1997 .

[7]  A. di Lenarda,et al.  Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group. , 1997, European heart journal.

[8]  Graves Ej,et al.  1994 summary: National Hospital Discharge Survey. , 1996, Advance data.

[9]  R. Vasan,et al.  The progression from hypertension to congestive heart failure. , 1996, JAMA.

[10]  D. Lackland,et al.  Epidemiology of hypertension in African Americans. , 1996, Seminars in nephrology.

[11]  Kannel Wb.  Need and prospects for prevention of cardiac failure. , 1996 .

[12]  S. Yusuf,et al.  Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .

[13]  M. Schechter,et al.  Learning about HIV-2 , 1994, The Lancet.

[14]  W. Kannel,et al.  Changing epidemiological features of cardiac failure. , 1994, British heart journal.

[15]  P. Whelton.  Epidemiology of hypertension , 1994, The Lancet.

[16]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[17]  M. Kronenberg,et al.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. , 1993, Circulation.

[18]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[19]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[20]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland 1980-1990. , 1993, European heart journal.

[21]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[22]  P E Leaverton,et al.  Prevalence and mortality rate of congestive heart failure in the United States. , 1992, Journal of the American College of Cardiology.

[23]  S. Yusuf,et al.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. , 1992, Circulation.

[24]  B. Gersh,et al.  The Clinical Course of Idiopathic Dilated Cardiomyopathy , 1992, Annals of Internal Medicine.

[25]  Brophy Jm.  Epidemiology of congestive heart failure: Canadian data from 1970 to 1989. , 1992 .

[26]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[27]  A J Belanger,et al.  Epidemiology of heart failure. , 1991, American heart journal.

[28]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[29]  R. Gillum.  Idiopathic cardiomyopathy in the United States, 1970-1982. , 1986, American heart journal.

[30]  C. Furberg,et al.  Effect of drug therapy on survival in chronic heart failure. , 1986, Advances in cardiology.

[31]  W. M. Smith.  Epidemiology of congestive heart failure. , 1985, The American journal of cardiology.

[32]  N. S. Stern.  Anomaly of the right coronary artery in a young patient with aortic valvular disease, cardiac enlargement, and angina pectoris , 1936 .